Member Login
  1. Stocks
    2. /
  2. Indivior Plc (LSE: INDV)
    3. /

LSE:INDV (Indivior Plc)

About INDV

Indivior PLC is a holding company, which engages in the development, manufacture and sale of buprenorphine-based prescription drugs for treatment of opioid dependence. Its products include Suboxone Film, Suboxone Tablet, and Subutex Tablet. It operates through the following geographical segments: United States, Rest of World, and United Kingdom. The company was founded on September 26, 2014 and is headquartered in Slough, the United Kingdom.
Financial Market Data copyright © 2025 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.

    • Indivior Plc (LSE: INDV) Latest News

    Investing Articles

    Forget 1.5% from a cash ISA. FTSE 100 member AstraZeneca is up by 20% in 2018

    | Roland Head

    Roland Head asks whether FTSE 100 (INDEXFTSE:UKX) dividend stock AstraZeneca plc (LON:AZN) deserves a buy rating.

    Read more »

    Investing Articles

    These FTSE 250 stocks have plunged 50% in 12 months. Is it time to buy?

    | Rupert Hargreaves

    These falling FTSE 250 (INDEXFTSE: MCX) stocks could be worth a look, according to Rupert Hargreaves.

    Read more »

    Investing Articles

    Is Indivior a falling knife to buy after plunging 20%?

    | Alan Oscroft

    Indivior plc (LON: INDV) shares crash on a profit warning, but is it an oversold bargain to snap up?

    Read more »

    Investing Articles

    Are these the cheapest growth stocks in the FTSE 250?

    | Rupert Hargreaves

    Should you buy, sell or hold these two FTSE 250 (INDEXFTSE: MCX) growth stocks?

    Read more »

    Investing Articles

    Why the Indivior share price could be a FTSE 250 buy after today’s 30% fall

    | Roland Head

    Roland Head looks at the numbers behind today's profit warning from FTSE 250 (INDEXFTSE:MCX) pharma stock Indivior plc (LON:INDV).

    Read more »

    Investing Articles

    2 growth champions I’d buy and hold for two decades

    | Rupert Hargreaves

    These companies have room to expand rapidly over the next 20 years.

    Read more »

    Investing Articles

    2 FTSE 250 pharma stocks I’d buy today and hold for another five years

    | Roland Head

    Roland Head takes a look at two unusual pharma stocks with long-term growth potential.

    Read more »

    Investing Articles

    2 stocks I’d invest £1,000 in right now

    | Kevin Godbold

    If you are looking for decent share ideas, check out these two that reported on Thursday.

    Read more »

    Investing Articles

    2 no-brainer stocks I’d buy in pharma

    | Royston Wild

    Royston Wild reveals two pharma stocks with the capability to deliver knockout profits growth.

    Read more »

    Investing Articles

    2 monster stocks in the making I’d buy today

    | Peter Stephens

    These two shares could post high total returns.

    Read more »

    Investing Articles

    2 growth stocks I’d buy and hold for 2018

    | Roland Head

    Roland Head takes a look at two promising growth stocks from his watch list.

    Read more »

    Investing Articles

    2 soaring growth stocks I’d consider buying today

    | Harvey Jones

    These two stocks have grown strongly in recent years and Harvey Jones expects further progress.

    Read more »